体内
激酶
化学
药理学
细胞因子
功能(生物学)
磷酸化
免疫系统
IC50型
细胞生物学
基因剔除小鼠
体外
生物化学
生物
免疫学
受体
生物技术
作者
Thomas B. Sundberg,Yanke Liang,Huixian Wu,Hwan Geun Choi,Nam Doo Kim,Taebo Sim,Liv Johannessen,Adam Petrone,Bernard Khor,Daniel B. Graham,Isabel Latorre,Andrew J. Phillips,Stuart L. Schreiber,José R. Perez,Alykhan F. Shamji,Nathanael S. Gray,Ramnik J. Xavier
标识
DOI:10.1021/acschembio.6b00217
摘要
Salt-inducible kinases (SIKs) are promising therapeutic targets for modulating cytokine responses during innate immune activation. The study of SIK inhibition in animal models of disease has been limited by the lack of selective small-molecule probes suitable for modulating SIK function in vivo. We used the pan-SIK inhibitor HG-9-91-01 as a starting point to develop improved analogs, yielding a novel probe 5 (YKL-05-099) that displays increased selectivity for SIKs versus other kinases and enhanced pharmacokinetic properties. Well-tolerated doses of YKL-05-099 achieve free serum concentrations above its IC50 for SIK2 inhibition for >16 h and reduce phosphorylation of a known SIK substrate in vivo. While in vivo active doses of YKL-05-099 recapitulate the effects of SIK inhibition on inflammatory cytokine responses, they did not induce metabolic abnormalities observed in Sik2 knockout mice. These results identify YKL-05-099 as a useful probe to investigate SIK function in vivo and further support the development of SIK inhibitors for treatment of inflammatory disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI